secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anteris Technologies Global Corp. (AVR)
CIK:        0002011514
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001140361-25-043801
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Anteris Technologies not renewing supply agreement with 4C Medical for ADAPT tissue
--------------------------------------------------------------------------------

- On Nov 26, 2025, Anteris notified 4C Medical of non-renewal of Second Amended Supply and License Agreement.
- Agreement supplied ADAPT tissue for 4C's transcatheter mitral/tricuspid valve devices; term would expire June 1, 2026.
- No early termination penalties incurred; company states termination does not materially impact financial results.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2011514/000114036125043801/0001140361-25-043801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2011514/000114036125043801/ef20060235_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-043801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer